MediSetter Interview:Â Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
L&K Biomed IPO Part 1 - Schedule, Financials & Valuation
L&K Biomed Co., Ltd. develops and manufactures medical devices such as cervical spine devices, 3D wholebody scanner and bio-similar products....
No more insights